Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Free Cash Flow: 2023-2024

Historic Free Cash Flow for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$59.7 million.

  • Upstream Bio's Free Cash Flow fell 59.75% to -$22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.5 million, marking a year-over-year decrease of 120.06%. This contributed to the annual value of -$59.7 million for FY2024, which is 56.77% down from last year.
  • Per Upstream Bio's latest filing, its Free Cash Flow stood at -$59.7 million for FY2024, which was down 56.77% from -$38.1 million recorded in FY2023.
  • Upstream Bio's 5-year Free Cash Flow high stood at -$38.1 million for FY2023, and its period low was -$59.7 million during FY2024.
  • In the last 2 years, Upstream Bio's Free Cash Flow had a median value of -$48.9 million in 2023 and averaged -$48.9 million.
  • Data for Upstream Bio's Free Cash Flow shows a maximum YoY tumbled of 56.77% (in 2024) over the last 5 years.
  • Upstream Bio's Free Cash Flow (Yearly) stood at -$38.1 million in 2023, then crashed by 56.77% to -$59.7 million in 2024.